Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture

Impact · against what's priced in

The extension of the Ginkgo-Bayer partnership provides a modest positive catalyst for DNA by validating its platform and securing a continued revenue stream. For Bayer, the news is marginally positive as it maintains access to Ginkgo's R&D for high-value microbial nitrogen fixation.

DNA+0.30

No priced-in read yet